You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 814 Cutaneous immune-related adverse events are protective of mortality in patients treated with anti-PD1 and anti-PDL1 therapy in a multi-institutional cohort study

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
814 Cutaneous immune-related adverse events are protective of mortality in patients treated with anti-PD1 and anti-PDL1 therapy in a multi-institutional cohort study
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to September 2024

AbstractFullPdf
Nov 2021178016
Dec 20215202
Jan 20224204
Feb 20225007
Mar 20229805
Apr 20225409
May 20224209
Jun 20222007
Jul 2022800
Aug 20225006
Sep 20222606
Oct 20223008
Nov 20221805
Dec 20222603
Jan 20232401
Feb 20232202
Mar 20231402
Apr 2023602
May 2023803
Jun 20232404
Jul 20231807
Aug 20232206
Sep 202318010
Oct 20231605
Nov 202336010
Dec 20234004
Jan 20242405
Feb 20242403
Mar 20243405
Apr 20242002
May 20241603
Jun 20242807
Jul 20242002
Aug 20241407
Sep 20243404
Total11560181